Clinical Trials Browser

Phase 1/2 × Psoriasis × Clear all

NCT00585650 2023-08-18

Study of Tumor Necrosis Factor Receptor Fusion Protein Etanercept (Enbrel) in Psoriasis of the Hands and/or Feet

Phase 1/2 Completed

20 enrolled 5 charts

Psoriasis

NCT00129415 2015-05-22

Ultraviolet (UVA and UVB) Light Therapy in the Treatment of Inflammatory Skin Conditions

Phase 1/2 Terminated

DermatologicLymphoid

Alopecia, Dermatitis, Atopic, Mycosis Fungoides, Psoriasis, Skin Diseases, Urticaria, Lymphoma, T-Cell, Cutaneous, Striae Distensae